# AVTOZMA

NDC: 72606-044
Generic name: tocilizumab
Labeler / Manufacturer: CELLTRION USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250126

FDA application: BLA761420

## Active ingredients

- TOCILIZUMAB: 400 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72606-044"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72606-044
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=581c288f-8015-40ef-a4c3-683c96db193d